Strong decrease in invasive ability and outer membrane vesicle release in Crohn's disease-associated

Nathalie Rolhion1, Nicolas Barnich, Laurent Claret

  • 1Pathogénie Bactérienne Intestinale, Laboratoire de Bactériologie, Université d'Auvergne, CBRV, 28 Place Henri Dunant, 63001 Clermont-Ferrand, France.

Insights

Adherent-invasive Escherichia coli uses YfgL protein to release outer membrane vesicles, which are crucial for invading intestinal cells. Deleting yfgL impairs this invasion process in Crohn's disease models.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Cell Biology

Background:

  • Adherent-invasive Escherichia coli (AIEC) strain LF82, isolated from Crohn's disease patients, invades intestinal epithelial cells.
  • Outer membrane vesicles (OMVs) are implicated in bacterial pathogenesis and host-pathogen interactions.

Purpose of the Study:

  • To investigate the role of the yfgL gene and its encoded lipoprotein (YfgL) in AIEC LF82's ability to invade intestinal epithelial cells.
  • To determine the impact of yfgL deletion on the production and release of outer membrane proteins and vesicles.

Main Methods:

  • Genetic manipulation to create yfgL-negative isogenic mutants of AIEC LF82.
  • Invasion assays using Intestine-407 cell cultures.
  • Analysis of outer membrane proteins in culture supernatants using SDS-PAGE and MALDI-TOF MS.
  • Western blot analysis and transmission electron microscopy (TEM) to characterize outer membrane vesicles.

Main Results:

  • Deletion of the yfgL gene significantly reduced the invasion ability of AIEC LF82.
  • The yfgL mutant showed decreased release of outer membrane proteins (OmpA, OmpC) into the supernatant.
  • Characterization confirmed that released proteins were part of outer membrane vesicles, and yfgL deletion decreased OMV release.
  • Complementation with the yfgL gene restored both invasion ability and OMV release.

Conclusions:

  • The YfgL lipoprotein plays a critical role in the biogenesis or release of outer membrane vesicles in AIEC LF82.
  • Reduced OMV release due to yfgL deletion directly correlates with impaired intestinal epithelial cell invasion.
  • Targeting YfgL or OMV production may represent a novel therapeutic strategy against AIEC infections in Crohn's disease.

Related Concept Videos

Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
Stringent Response in E. coli01:23

Stringent Response in E. coli

Bacterial growth is closely tied to nutrient availability, with cells proliferating exponentially under favorable conditions and entering a stationary phase when resources become scarce. This transition is mediated by a regulatory mechanism known as the stringent response, which allows bacteria to adapt to nutrient deprivation by modulating gene expression and metabolic activity.During nutrient scarcity, intracellular amino acid levels decline. It results in the accumulation of uncharged tRNAs...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...